Tag: Extends
-
Novartis' Glivec extends European GIST licence
Novartis' Glivec extends European GIST licence Novartis' cancer therapy Glivec (imatinib) can now be used in Europe to treat specific patients with gastrointestinal stromal tumours (GIST) up to 3 years right after surgery. The European Commission (EC) has approved an update to the labelling for the … Read much more on PMLiVE Positive Vote for…
-
Nexavar Extends Survival without Progression in Liver and Kidney Cancer
Article by Chani Prem T Hepatocellular Carcinoma (HCC), a liver cancer, and advanced renal cell cancer (ARCC) are two illnesses that are treated with Nexavar. It acts by interfering with the growth of cancer cells, thereby, reducing the threat of liver and kidney cancer. The drug is readily available in 200mg dosage in brand, as…